Nina Kjellson has been a General Partner at Canaan since 2015 and invests in biopharma and digital health start-ups that serve high unmet needs. She has 20 years of experience funding, growing and transacting early-stage companies. As a leader of Canaan’s Women of Venture program, Nina is a vocal advocate for female entrepreneurs and investors. She serves as an advisor to Springboard Life Sciences, Nina Capital (no relation), The Gates Foundation and serves on the boards of Essential Access Health, Girl Effect and the Oliver Wyman Health Innovation Center.